<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="1-part\PMC6429326\results\search\tropicalVirus\results.xml">
  <result pre="Molecular Sciences1422-0067MDPI pmcid: 6429326 doi: 10.3390/ijms20051101ijms-20-01101 : Review Advances in" exact="Zika" post="Virus–Host Cell Interaction: Current Knowledge and Future Perspectives LeeJae"/>
  <result pre="BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract Emerging mosquito-transmitted RNA viruses, such as" exact="Zika" post="virus (ZIKV) and Chikungunya represent human pathogens of an"/>
  <result pre="Emerging mosquito-transmitted RNA viruses, such as Zika virus (ZIKV) and" exact="Chikungunya" post="represent human pathogens of an immense global health problem."/>
  <result pre="human pathogens of an immense global health problem. In particular," exact="ZIKV" post="has emerged explosively since 2007 to cause a series"/>
  <result pre="South Pacific and most recently in the Americas. Although typical" exact="ZIKV" post="infections are asymptomatic, ZIKV infection during pregnancy is increasingly"/>
  <result pre="recently in the Americas. Although typical ZIKV infections are asymptomatic," exact="ZIKV" post="infection during pregnancy is increasingly associated with microcephaly and"/>
  <result pre="have established a remarkable progress on the pathogenic mechanisms of" exact="ZIKV" post="infection using in vitro and in vivo models. Here,"/>
  <result pre="ZIKV-mediated cell death mechanisms, host cell restriction factors that limit" exact="ZIKV" post="replication, and immune evasion mechanisms utilized by ZIKV. Understanding"/>
  <result pre="cellular level will contribute crucial insights into the development of" exact="ZIKV" post="therapeutics and vaccines. Zika virus cellular targets innate immune"/>
  <result pre="crucial insights into the development of ZIKV therapeutics and vaccines." exact="Zika" post="virus cellular targets innate immune evasion cell death 1."/>
  <result pre="as dengue virus (DENV), chikungunya, yellow fever virus (YFV), and" exact="Zika" post="virus (ZIKV) has become possible due to several factors"/>
  <result pre="autoimmune disorders in adults, and neurodevelopmental complications in newborns [2,3]." exact="ZIKV" post="belongs to the Flaviviridae family along with Japanese encephalitis"/>
  <result pre="to the Flaviviridae family along with Japanese encephalitis virus (JEV)," exact="West Nile" post="virus (WNV), and DENV, all of which are medically"/>
  <result pre="ticks. As of January 2018, PAHO has reported 223,477 confirmed" exact="ZIKV" post="cases that have cumulated worldwide between 2015 and 2018"/>
  <result pre="combat the infections [5]. As a result, international concern surrounding" exact="ZIKV" post="in terms of control, treatment, and prevention has classified"/>
  <result pre="a global threat to public health. Although most cases of" exact="ZIKV" post="infection result in asymptomatic or mild flu-like symptoms, such"/>
  <result pre="microcephaly and spontaneous abortion [6]. Up to date, diagnosis of" exact="ZIKV" post="infection has depended on molecular and serological testing, employing"/>
  <result pre="decline over time. Laboratory testing of infants suspected of congenital" exact="ZIKV" post="infection includes detection of viral RNA in serum and"/>
  <result pre="detection remain undetermined. Since the series of outbreaks in 2007," exact="ZIKV" post="infection has increasingly been associated with cases of neurological"/>
  <result pre="below the mean, is one clinical presentation of a congenital" exact="ZIKV" post="infection, and the World Health Organization has already established"/>
  <result pre="World Health Organization has already established an etiological link between" exact="ZIKV" post="infection and birth defects like microcephaly in Brazil [7,9]."/>
  <result pre="defects like microcephaly in Brazil [7,9]. Congenital abnormalities induced by" exact="ZIKV" post="infection have confirmed the possibility of vertical transmission. Despite"/>
  <result pre="neuropathogenesis remains unclear [7]. In addition to microcephaly, exposure to" exact="ZIKV" post="during pregnancy can result in visual and hearing impairments"/>
  <result pre="newborn [11]. Thus, the phenotypic spectrum of outcomes of pregnancy-associated" exact="ZIKV" post="infection has identified ZIKV as a dangerous and atypical"/>
  <result pre="phenotypic spectrum of outcomes of pregnancy-associated ZIKV infection has identified" exact="ZIKV" post="as a dangerous and atypical member among the flaviviruses."/>
  <result pre="the level of cellular mechanisms and interactions. 2. Structure of" exact="ZIKV" post="ZIKV is a single stranded, positive sense RNA virus"/>
  <result pre="level of cellular mechanisms and interactions. 2. Structure of ZIKV" exact="ZIKV" post="is a single stranded, positive sense RNA virus whose"/>
  <result pre="responsible for viral replication and assembly [5,13]. The structure of" exact="ZIKV" post="is similar to that of other flaviviruses. Flaviviral NS1"/>
  <result pre="flavivirus genus, NS5 plays an important role in viral replication." exact="ZIKV" post="NS5 contains an RNA dependent RNA polymerase (RdRp) domain,"/>
  <result pre="[16]. The envelope (E) protein, which mediates viral entry, of" exact="ZIKV" post="possesses a highly conserved fusion loop region that is"/>
  <result pre="target for antibodies generated against broad range of flaviviruses like" exact="DENV" post="and ZIKV [13,20]. Furthermore, transposon mutagenesis screening has demonstrated"/>
  <result pre="antibodies generated against broad range of flaviviruses like DENV and" exact="ZIKV" post="[13,20]. Furthermore, transposon mutagenesis screening has demonstrated the capacity"/>
  <result pre="[13,20]. Furthermore, transposon mutagenesis screening has demonstrated the capacity of" exact="ZIKV" post="to tolerate genetic diversity, as evident from ZIKV E"/>
  <result pre="capacity of ZIKV to tolerate genetic diversity, as evident from" exact="ZIKV" post="E gene’s tolerance of mutations, and this genetic flexibility"/>
  <result pre="promote host cell death. 3. Cellular Entry and Targets of" exact="ZIKV" post="Since 2016, scientific communities have dedicated rapid and extensive"/>
  <result pre="scientific communities have dedicated rapid and extensive research efforts on" exact="ZIKV" post="in terms of its molecular pathogenesis and associated cellular"/>
  <result pre="a comprehensive list of currently identified susceptible human cells to" exact="ZIKV" post="infection. ZIKV exhibits broad tropism, and the localization of"/>
  <result pre="list of currently identified susceptible human cells to ZIKV infection." exact="ZIKV" post="exhibits broad tropism, and the localization of its cellular"/>
  <result pre="and skin, to testis, kidney, and retina. The entry of" exact="ZIKV" post="is facilitated by the following phosphotidylserine receptors, such as"/>
  <result pre="the epidermis and dermis were primarily considered as targets for" exact="ZIKV" post="infection [25,26]. Upon entry of the host cell by"/>
  <result pre="infection [25,26]. Upon entry of the host cell by endocytosis," exact="ZIKV" post="releases a viral genome that undergoes replication and virion"/>
  <result pre="that undergoes replication and virion assembly for further infection [12]." exact="ZIKV" post="infection exhibits broad distribution and persistence in body tissues"/>
  <result pre="persistence in body tissues and fluids, a characteristic that distinguishes" exact="ZIKV" post="from other arthropod-transmitted flaviviruses. For example, the presence of"/>
  <result pre="ZIKV from other arthropod-transmitted flaviviruses. For example, the presence of" exact="ZIKV" post="has been detected in the amniotic fluid of pregnant"/>
  <result pre="[27]. As previously mentioned, microcephaly is a severe consequence of" exact="ZIKV" post="infection in the prenatal brain. Despite the existence of"/>
  <result pre="cells were preferentially targeted by ZIKV. Furthermore, the capability of" exact="ZIKV" post="to infect human neural progenitor cells (NPCs) has been"/>
  <result pre="neural progenitor cells (NPCs) has been confirmed in several studies." exact="ZIKV" post="exhibits preferential infection of neural progenitor cells, leading to"/>
  <result pre="and inhibition of NPC differentiation. All of these outcomes following" exact="ZIKV" post="infection are associated with delayed development and birth defects,"/>
  <result pre="as microcephaly in the mouse model [30]. Prenatal infection of" exact="ZIKV" post="has adverse pregnancy effects that range from congenital abnormalities"/>
  <result pre="the placenta possesses innate immunity to defend against infiltrating pathogens," exact="ZIKV" post="infection is able to overcome this defense and cross"/>
  <result pre="placental macrophages called Hofbauer cells may take part in spreading" exact="ZIKV" post="in the placenta and promoting vertical transmission of ZIKV"/>
  <result pre="spreading ZIKV in the placenta and promoting vertical transmission of" exact="ZIKV" post="[36]. In accordance, El Costa et al. identified the"/>
  <result pre="Hofbauer cells, suggesting that these cells provide a pathway for" exact="ZIKV" post="to reach fetal cells, resulting in a congenital infection"/>
  <result pre="these immune cells during pregnancy, especially in context of congenital" exact="ZIKV" post="infection, further research is needed to determine the exact"/>
  <result pre="further research is needed to determine the exact mechanism that" exact="ZIKV" post="employs to infect the placental immune cells and its"/>
  <result pre="a concerning threat to people who are outside of the" exact="ZIKV" post="epidemic-prone regions. Previous knowledge of flaviviruses as exclusively vector-borne"/>
  <result pre="as exclusively vector-borne diseases was contested when a case of" exact="ZIKV" post="infection resulted in a human-to-human transmission in 2008, between"/>
  <result pre="of samples from infected patients revealed infectious viral load of" exact="ZIKV" post="in semen [51]. Furthermore, the prolonged presence of ZIKV"/>
  <result pre="of ZIKV in semen [51]. Furthermore, the prolonged presence of" exact="ZIKV" post="RNA differentiates ZIKV from other flaviviruses because the immune"/>
  <result pre="semen [51]. Furthermore, the prolonged presence of ZIKV RNA differentiates" exact="ZIKV" post="from other flaviviruses because the immune response usually clears"/>
  <result pre="timeframe after symptom onset. Mansuy et al. describes cases of" exact="ZIKV" post="infection in which viral RNA was detected up to"/>
  <result pre="detection in urine and blood samples [51]. Sexual transmission of" exact="ZIKV" post="also results in a longer incubation period compared to"/>
  <result pre="may result from differences in the timing and/or site of" exact="ZIKV" post="infection, both factors that can affect the tropism and"/>
  <result pre="propagation mode exhibited by the virus. Immunohistochemistry has also detected" exact="ZIKV" post="in the head of spermatozoa, which does not express"/>
  <result pre="level of Axl, are hypothesized to be involved in transmitting" exact="ZIKV" post="to spermatozoa [57]. In Yockey et al. (2016), the"/>
  <result pre="(2016), the vagina was identified as another site susceptible to" exact="ZIKV" post="infection, and sustained a viral replication that was more"/>
  <result pre="robust than other organs [58]. Although rare, sexual transmission of" exact="ZIKV" post="cannot be overlooked as this route has implications on"/>
  <result pre="ZIKV cannot be overlooked as this route has implications on" exact="ZIKV" post="infection in relation to male fertility, pregnancy, and viral"/>
  <result pre="infection in relation to male fertility, pregnancy, and viral persistence." exact="ZIKV" post="infection is also capable of breaching the blood–retinal barrier,"/>
  <result pre="the ocular symptoms. Although an immune privilege organ, an ocular" exact="ZIKV" post="infection manifests as conjunctivitis and pan-uveitis, the former being"/>
  <result pre="iris, along with the optic nerve [60]. Ocular manifestations of" exact="ZIKV" post="infection demonstrate viral pathogenesis in previously uninvestigated sites. Despite"/>
  <result pre="pathogenesis in previously uninvestigated sites. Despite the tropism displayed by" exact="ZIKV" post="infection for specific regions of the eye, further studies"/>
  <result pre="outline the exact mechanisms of ZIKV-induced ocular disease. Evidence of" exact="ZIKV" post="infection persisting in organs such as the eyes and"/>
  <result pre="sites of viral replication and persistence [59,61,62]. Preferential targets of" exact="ZIKV" post="infection exhibited high expression levels of entry receptor genes,"/>
  <result pre="human fetal cerebral cortex provides a possible explanation for why" exact="ZIKV" post="selectively targets these neural stem cells and a potential"/>
  <result pre="interaction and kinase activity of Axl, accordingly, to ultimately inhibit" exact="ZIKV" post="infection [41]. It is interesting to note the dual"/>
  <result pre="against neurotropism [65,66]. Consequently, inhibiting Axl function to protect against" exact="ZIKV" post="infection may have adverse outcomes that require consideration when"/>
  <result pre="potential therapeutic targets. 4. Multiple Cell Death Pathways Induced by" exact="ZIKV" post="Infection In addition to antiviral responses, a virus infection"/>
  <result pre="studies have confirmed the occurrence of neuronal apoptosis following a" exact="ZIKV" post="infection in vivo and in vitro [68,69]. NSCs and"/>
  <result pre="In efforts to determine the reasons for the cell deaths," exact="ZIKV" post="structural envelope (E) protein, and its truncated forms, were"/>
  <result pre="Wu et al. also describes the potential inhibitory role of" exact="ZIKV" post="NS2B-NS3 (NS2B3) on apoptosis [71]. Overexpression of NS2B3 in"/>
  <result pre="suggests paraptosis as another form of cell death induced by" exact="ZIKV" post="infection, during which formation of large cytoplasmic vacuoles, which"/>
  <result pre="cellular death pathways have been suggested to be induced upon" exact="ZIKV" post="infection. It will be interesting to further study an"/>
  <result pre="the survival strategy. 5. Host Cell Restriction Factors that Limit" exact="ZIKV" post="Replication Through active interference with viral replication in various"/>
  <result pre="the host immune response. Belonging to the same flavivirus genus," exact="DENV" post="and ZIKV share similarities beyond phylogeny, including host immune"/>
  <result pre="immune response. Belonging to the same flavivirus genus, DENV and" exact="ZIKV" post="share similarities beyond phylogeny, including host immune responses. Proteins"/>
  <result pre="α, β, ε, τ, and δ) exhibited contradictory roles in" exact="DENV" post="pathogenesis, during which certain proteins were upregulated compared to"/>
  <result pre="[79,80,81,82,83]. In vitro studies of type III IFNs induction following" exact="DENV" post="infection demonstrated that IFN-λ has the inhibitory potential to"/>
  <result pre="infection demonstrated that IFN-λ has the inhibitory potential to control" exact="DENV" post="replication [84]. In Bayer et al., IFN- λ1 of"/>
  <result pre="of the type III IFN family (λ1-4) conferred protection against" exact="ZIKV" post="infection in placental trophoblasts, mediating antiviral signaling at the"/>
  <result pre="paracrine manner to protect other syncytiotrophoblasts and non-placental cells from" exact="ZIKV" post="infection [37]. According to Chaudhary et al., ZIKV infection"/>
  <result pre="cells from ZIKV infection [37]. According to Chaudhary et al.," exact="ZIKV" post="infection had differential effects on type I and type"/>
  <result pre="type II IFN responses, as demonstrated by the ability of" exact="ZIKV" post="NS5 to suppress type I and type III IFN"/>
  <result pre="inhibit viral replication of various pathogens including flaviviruses such as" exact="WNV" post="and DENV [88,89,90,91,92]. In Savidis et al., gain- and"/>
  <result pre="replication of various pathogens including flaviviruses such as WNV and" exact="DENV" post="[88,89,90,91,92]. In Savidis et al., gain- and loss-of function"/>
  <result pre="of ZIKV, and IFITM3 specifically inhibited the early stages of" exact="ZIKV" post="replication, evident from the significant decrease in the expression"/>
  <result pre="IFITM3 may be responsible for mounting an initial defense against" exact="ZIKV" post="infection even before the induction of interferon signaling and"/>
  <result pre="mechanism for the prevention and treatment of viral infections including" exact="ZIKV" post="[88,89,90,91,93]. Small non-coding RNAs are another potential restriction factor"/>
  <result pre="non-coding RNAs are another potential restriction factor that can limit" exact="ZIKV" post="replication. MicroRNA (miRNA) have been shown to have a"/>
  <result pre="MicroRNA (miRNA) have been shown to have a role during" exact="ZIKV" post="infection by regulating a broad spectrum of cellular processes"/>
  <result pre="study the antiviral role of differentially regulated small RNAs during" exact="ZIKV" post="infection. 6. Immune Evasion Mechanisms Utilized by ZIKV The"/>
  <result pre="RNAs during ZIKV infection. 6. Immune Evasion Mechanisms Utilized by" exact="ZIKV" post="The efficient replication of flaviviruses is associated with the"/>
  <result pre="molecules involved in innate immunity to establish efficient viral replication." exact="ZIKV" post="infection leads to the inhibition of type I IFN"/>
  <result pre="I IFN production and downstream interferon stimulated genes (ISGs) [97]." exact="ZIKV" post="NS1, NS4A, and NS4B proteins function as the main"/>
  <result pre="of TBK1/IRF3 pathways. Figure 2 describes diverse mechanisms by which" exact="ZIKV" post="evade innate immune responses. Nonstructural proteins have roles during"/>
  <result pre="replication and immune evasion, as seen during the pathogenesis of" exact="DENV" post="[98]. The amino acid differences in NS1 proteins may"/>
  <result pre="host immune response is differentially modulated to viruses such as" exact="ZIKV" post="in comparison to DENV. Furthermore, by interacting with host"/>
  <result pre="IFN-α and β signaling [100]. Furthermore, NS1 and NS4B of" exact="ZIKV" post="inhibit production of type I IFN by targeting TBK1,"/>
  <result pre="a manner independent of NS2B3-mediated Jak1 degradation. The focus on" exact="WNV" post="NS5 has been centered on its ability to inhibit"/>
  <result pre="of the mechanism for immune evasion [101,102]. Similarly, NS5 of" exact="ZIKV" post="directly interacts with and induces degradation of STAT2, which"/>
  <result pre="that has been targeted by various viruses closely related to" exact="DENV" post="[97,103]. In Kumar et al., immunoblot and confocal microscopy"/>
  <result pre="remained unchanged, the levels of STAT2 were nearly abrogated following" exact="ZIKV" post="infection [97]. While ZIKV NS5 is utilized for evasion"/>
  <result pre="of STAT2 were nearly abrogated following ZIKV infection [97]. While" exact="ZIKV" post="NS5 is utilized for evasion of type I IFN"/>
  <result pre="Akt-mTOR pathway has also been identified as a target of" exact="ZIKV" post="proteins NS4A and NS4B for neurogenesis inhibition and autophagy"/>
  <result pre="NS4A and NS4B for neurogenesis inhibition and autophagy induction [105]." exact="DENV" post="and ZIKV both induce autophagy through NS4 protein in"/>
  <result pre="NS4B for neurogenesis inhibition and autophagy induction [105]. DENV and" exact="ZIKV" post="both induce autophagy through NS4 protein in order to"/>
  <result pre="in enhanced viral replication. Taken together, the nonstructural proteins of" exact="ZIKV" post="work synergistically to restrict host antiviral response at multiple"/>
  <result pre="host immune system. 7. Vaccines and Therapeutics The reemergence of" exact="ZIKV" post="has posed a serious threat to global public health"/>
  <result pre="for the development of effective vaccines and therapeutic treatments against" exact="ZIKV" post="infection. Animal models have demonstrated the efficacy of various"/>
  <result pre="have advanced to human trials [106,107]. Furthermore, modified mRNA encoding" exact="ZIKV" post="prM-E and live-attenuated ZIKV with NS1 mutations studied in"/>
  <result pre="trials [106,107]. Furthermore, modified mRNA encoding ZIKV prM-E and live-attenuated" exact="ZIKV" post="with NS1 mutations studied in pregnant mice showed promising"/>
  <result pre="mice showed promising potential to protect against placental and fetal" exact="ZIKV" post="infection, preventing congenital ZIKV syndrome [107]. Richner et al."/>
  <result pre="to protect against placental and fetal ZIKV infection, preventing congenital" exact="ZIKV" post="syndrome [107]. Richner et al. demonstrated that vaccination with"/>
  <result pre="with the two previously described platforms protected against challenge with" exact="ZIKV" post="during pregnancy, as evident from the following: reduced level"/>
  <result pre="findings of current vaccine platforms that have sufficient immunity against" exact="ZIKV" post="infection in animal models, a more comprehensive evaluation of"/>
  <result pre="future. In addition to the lack of preventable methods against" exact="ZIKV" post="infection, the increased pathogenicity of the virus has triggered"/>
  <result pre="drugs that have already been FDA-approved is screened for potential" exact="ZIKV" post="inhibitors, has also risen as a viable alternative that"/>
  <result pre="potential through various screening methods [110,111,112]. Furthermore, the ability of" exact="ZIKV" post="to cross barriers into sites previously considered as immune"/>
  <result pre="exhibited potential antiviral activities against flaviviruses including ZIKV, DENV, and" exact="WNV" post="[113]. A member of the largest family of polyphenols,"/>
  <result pre="of polyphenols, the flavonoid isoquercitrin also demonstrated antiviral effect against" exact="ZIKV" post="by acting on viral entry [114]. A bacterially derived"/>
  <result pre="A bacterially derived nanchangmycin is another natural compound that inhibited" exact="ZIKV" post="entry in human osteosarcoma cells (U2OS), human brain microvascular"/>
  <result pre="[115]. Furthermore, berberine and emodin showed strong inhibitory effect on" exact="ZIKV" post="infectivity in vitro [116]. 8. Future Directions for ZIKV"/>
  <result pre="on ZIKV infectivity in vitro [116]. 8. Future Directions for" exact="ZIKV" post="Studies Although remarkable progress in ZIKV research has created"/>
  <result pre="8. Future Directions for ZIKV Studies Although remarkable progress in" exact="ZIKV" post="research has created opportunities for the development of vaccines"/>
  <result pre="of future perspectives: 1) what is the mechanism by which" exact="ZIKV" post="crosses the placenta and infects developing fetus? 2) What"/>
  <result pre="developing fetus? 2) What host and viral factors contribute to" exact="ZIKV" post="persistence in the placenta and other immune-privileged sites? 3)"/>
  <result pre="sites? 3) What are the roles of noncoding RNAs during" exact="ZIKV" post="infection? Although animal models provide useful platforms for supplementing"/>
  <result pre="virus–host cell interactions and mechanisms associated with increased virulence of" exact="ZIKV" post="will better aid in the design and development of"/>
  <result pre="pandemic: A review of the state of knowledge on the" exact="Zika" post="virusPublic Health Rev.2018391010.1186/s40985-018-0087-629785319 3.LazearH.M.DiamondM.S.Zika Virus: New Clinical Syndromes and"/>
  <result pre="American Health Organization (PAHO)Zika Cases and Congenital Syndrome Associated with" exact="Zika" post="Virus Reported by Countries and Territories in the Americas,"/>
  <result pre="clinical manifestation, diagnosis, therapeutic strategies, vaccine developments, and challenges of" exact="Zika" post="virus researchFront. Microbiol.20178176110.3389/fmicb.2017.0176128959246 6.PiersonT.C.DiamondM.S.The emergence of Zika virus and"/>
  <result pre="and challenges of Zika virus researchFront. Microbiol.20178176110.3389/fmicb.2017.0176128959246 6.PiersonT.C.DiamondM.S.The emergence of" exact="Zika" post="virus and its new clinical syndromesNature201856057310.1038/s41586-018-0446-y30158602 7.FaizanM.I.AbdullahM.AliS.NaqviI.H.AhmedA.ParveenS.Zika virus-induced microcephaly"/>
  <result pre="the Diagnosis, Evaluation, and Management of Infants with Possible Congenital" exact="Zika" post="Virus Infection—United StatesMMWR Morb. Mortal. Wkly. Rep.2017661089109910.15585/mmwr.mm6641a129049277 9.JaenischT.RosenbergerK.D.BritoC.BradyO.BrasilP.MarquesE.T.J.Risk of"/>
  <result pre="Infection—United StatesMMWR Morb. Mortal. Wkly. Rep.2017661089109910.15585/mmwr.mm6641a129049277 9.JaenischT.RosenbergerK.D.BritoC.BradyO.BrasilP.MarquesE.T.J.Risk of microcephaly after" exact="Zika" post="virus infection in Brazil, 2015 to 2016Bull. World Health"/>
  <result pre="2016Bull. World Health Organ.20179519110.2471/BLT.16.17860828250532 10.Alvarado-SocarrasJ.L.Idrovo�?.J.Contreras-GarcíaG.A.Rodriguez-MoralesA.J.AudcentT.A.Mogollon-MendozaA.C.Paniz-MondolfiA.Congenital microcephaly: A diagnostic challenge during" exact="Zika" post="epidemicsTravel Med. Inf. Dis.201823142010.1016/j.tmaid.2018.02.00229471046 11.PeloggiaA.AliM.NandaK.BahamondesL.Zika virus exposure in pregnancy"/>
  <result pre="and abusing the host cellCell Host Microbe2009531832810.1016/j.chom.2009.04.00119380111 13.DaiL.SongJ.LuX.DengY.-Q.MusyokiA.M.ChengH.ZhangY.YuanY.SongH.HaywoodJ.Structures of the" exact="Zika" post="virus envelope protein and its complex with a flavivirus"/>
  <result pre="1 protein: Risks and benefitsVirus Res.2014181536010.1016/j.virusres.2014.01.00124434336 16.ShiY.GaoG.F.Structural Biology of the" exact="Zika" post="VirusTrends Biochem. Sci.20174244345610.1016/j.tibs.2017.02.00928318966 17.AlconS.TalarminA.DebruyneM.FalconarA.DeubelV.FlamandM.Enzyme-linked immunosorbent assay specific to Dengue"/>
  <result pre="the Zika VirusTrends Biochem. Sci.20174244345610.1016/j.tibs.2017.02.00928318966 17.AlconS.TalarminA.DebruyneM.FalconarA.DeubelV.FlamandM.Enzyme-linked immunosorbent assay specific to" exact="Dengue" post="virus type 1 nonstructural protein NS1 reveals circulation of"/>
  <result pre="secondary infectionsJ. Clin. Microbiol.20024037638110.1128/JCM.40.02.376-381.200211825945 18.PhooW.W.LiY.ZhangZ.LeeM.Y.LohY.R.TanY.B.NgE.Y.N.LescarJ.KangC.LuoD.Structure of the NS2B-NS3 protease from" exact="Zika" post="virus after self-cleavageNat. Commun.201671341010.1038/ncomms1341027845325 19.HeinzF.X.StiasnyK.The Antigenic Structure of Zika"/>
  <result pre="from Zika virus after self-cleavageNat. Commun.201671341010.1038/ncomms1341027845325 19.HeinzF.X.StiasnyK.The Antigenic Structure of" exact="Zika" post="Virus and Its Relation to Other Flaviviruses: Implications for"/>
  <result pre="Fusion Loop of E ProteinPLoS ONE20116e001605910.1371/journal.pone.001605921264311 21.FultonB.O.SachsD.SchwarzM.C.PaleseP.EvansM.J.Transposon Mutagenesis of the" exact="Zika" post="Virus Genome Highlights Regions Essential for RNA Replication and"/>
  <result pre="suggesting two routes for vertical transmissionCell Host Microbe20162015516610.1016/j.chom.2016.07.00227443522 25.HamelR.DejarnacO.WichitS.EkchariyawatP.NeyretA.NatthanejL.Perera-LecoinM.SurasombatpattanaP.TalignaniL.ThomasF.Biology of" exact="Zika" post="virus infection in human skin cellsJ. Virol.201510.1128/JVI.00354-1526085147 26.KimJ.-A.SeongR.-K.SonS.W.ShinO.S.Insights into"/>
  <result pre="Infect. Dis.20162028228910.1016/j.bjid.2016.02.00627102780 28.NowakowskiT.J.PollenA.A.Di LulloE.Sandoval-EspinosaC.BershteynM.KriegsteinA.R.Expression analysis highlights AXL as a candidate" exact="Zika" post="virus entry receptor in neural stem cellsCell Stem Cell20161859159610.1016/j.stem.2016.03.01227038591"/>
  <result pre="damage and fetal demiseCell20161651081109110.1016/j.cell.2016.05.00827180225 31.SunX.HuaS.ChenH.-R.OuyangZ.EinkaufK.TseS.ArdK.CiaranelloA.YawetzS.SaxP.J.et al.Transcriptional changes during naturally acquired" exact="Zika" post="virus infection render dendritic cells highly conducive to viral"/>
  <result pre="render dendritic cells highly conducive to viral replicationCell Rep.2017213471348210.1016/j.celrep.2017.11.08729262327 32.FooS.-S.ChenW.ChanY.BowmanJ.W.ChangL.-C.ChoiY.YooJ.S.GeJ.ChengG.BonninA.Asian" exact="Zika" post="virus strains target CD14+ blood monocytes and induce M2-skewed"/>
  <result pre="pregnancyNat. Microbiol.20172155810.1038/s41564-017-0016-328827581 33.MichlmayrD.AndradeP.GonzalezK.BalmasedaA.HarrisE.CD14+ CD16+ monocytes are the main target of" exact="Zika" post="virus infection in peripheral blood mononuclear cells in a"/>
  <result pre="in a paediatric study in NicaraguaNat. Microbiol.20172146210.1038/s41564-017-0035-028970482 34.RosenbergA.Z.YuW.HillD.A.ReyesC.A.SchwartzD.A.Placental pathology of" exact="Zika" post="virus: Viral infection of the placenta induces villous stromal"/>
  <result pre="of inflammation characterize the placental pathology of fetuses with congenital" exact="Zika" post="virus infectionArch. Gynecol. Obstet.20172951361136810.1007/s00404-017-4361-528396992 36.SimoniM.K.JuradoK.A.AbrahamsV.M.FikrigE.GullerS.Zika virus infection of Hofbauer"/>
  <result pre="III interferons produced by human placental trophoblasts confer protection against" exact="Zika" post="virus infectionCell Host Microbe20161970571210.1016/j.chom.2016.03.00827066743 38.TabataT.PetittM.Puerta-GuardoH.MichlmayrD.HarrisE.PereiraL.Zika Virus Replicates in Proliferating"/>
  <result pre="Sites for Dissemination of InfectionJ. Infect. Dis.20182171202121310.1093/infdis/jix55229106643 39.ChengF.da SilvaS.R.HuangI.-C.JungJ.U.GaoS.-J.Suppression of" exact="Zika" post="virus infection and replication in endothelial cells and astrocytes"/>
  <result pre="Not Protect Human Neural Progenitor Cells and Cerebral Organoids from" exact="Zika" post="Virus InfectionCell Stem Cell20161970370810.1016/j.stem.2016.11.01127912091 41.MeertensL.LabeauA.DejarnacO.CiprianiS.SinigagliaL.Bonnet-MadinL.Le CharpentierT.HafirassouM.L.ZamborliniA.Cao-LormeauV.-M.Axl mediates ZIKA virus"/>
  <result pre="cells and modulates innate immune responsesCell Rep.20171832433310.1016/j.celrep.2016.12.04528076778 42.StefanikM.FormanovaP.BilyT.VancovaM.EyerL.PalusM.SalatJ.BraconiC.T.ZanottoP.M.A.GouldE.A.et al.Characterisation of" exact="Zika" post="virus infection in primary human astrocytesBMC Neurosci.201819510.1186/s12868-018-0407-229463209 43.RoachT.AlcendorD.J.Zika virus"/>
  <result pre="diseaseJ. Neuroinflamm.2017144310.1186/s12974-017-0824-728253931 44.BagasraO.AddankiK.C.GoodwinG.R.HughesB.W.PandeyP.McLeanE.Cellular targets and receptor of sexual transmission of" exact="Zika" post="virusAppl. Immunohistochem. Mol. Morphol.20172567968610.1097/PAI.000000000000058028968270 45.SalamA.P.HorbyP.Isolation of viable Zika virus"/>
  <result pre="transmission of Zika virusAppl. Immunohistochem. Mol. Morphol.20172567968610.1097/PAI.000000000000058028968270 45.SalamA.P.HorbyP.Isolation of viable" exact="Zika" post="virus from spermatozoaLancet Infect. Dis.20181814410.1016/S1473-3099(18)30020-3 46.KumarA.JovelJ.Lopez-OrozcoJ.LimontaD.AiroA.M.HouS.StryapuninaI.FibkeC.MooreR.B.HobmanT.C.J.Human Sertoli cells support"/>
  <result pre="spermatozoaLancet Infect. Dis.20181814410.1016/S1473-3099(18)30020-3 46.KumarA.JovelJ.Lopez-OrozcoJ.LimontaD.AiroA.M.HouS.StryapuninaI.FibkeC.MooreR.B.HobmanT.C.J.Human Sertoli cells support high levels of" exact="Zika" post="virus replication and persistenceSci. Rep.20188547710.1038/s41598-018-23899-x29615760 47.SiemannD.N.StrangeD.P.MaharajP.N.ShiP.-Y.VermaS.Zika virus infects human"/>
  <result pre="J. Med.20163741981198710.1056/NEJMsr160433827074377 49.CalvetG.AguiarR.S.MeloA.S.SampaioS.A.De FilippisI.FabriA.AraujoE.S.de SequeiraP.C.de MendonçaM.C.de OliveiraL.Detection and sequencing of" exact="Zika" post="virus from amniotic fluid of fetuses with microcephaly in"/>
  <result pre="first trimester of pregnancySci. Rep.201663529610.1038/srep3529627759009 52.FoyB.D.KobylinskiK.C.FoyJ.L.C.BlitvichB.J.da RosaA.T.HaddowA.D.LanciottiR.S.TeshR.B.Probable non–vector-borne transmission of" exact="Zika" post="virus, Colorado, USAEmerg. Infect. Dis.20111788010.3201/eid1705.10193921529401 53.CounotteM.J.KimC.R.WangJ.BernsteinK.DealC.D.BroutetN.J.N.LowN.Sexual transmission of Zika"/>
  <result pre="of Zika virus, Colorado, USAEmerg. Infect. Dis.20111788010.3201/eid1705.10193921529401 53.CounotteM.J.KimC.R.WangJ.BernsteinK.DealC.D.BroutetN.J.N.LowN.Sexual transmission of" exact="Zika" post="virus and other flaviviruses: A living systematic reviewPLoS Med.201815e100261110.1371/journal.pmed.100261130040845"/>
  <result pre="flaviviruses: A living systematic reviewPLoS Med.201815e100261110.1371/journal.pmed.100261130040845 54.ArsuagaM.BujalanceS.G.Díaz-MenéndezM.VázquezA.ArribasJ.R.Probable sexual transmission of" exact="Zika" post="virus from a vasectomised manLancet Infect. Dis.201616110710.1016/S1473-3099(16)30320-6 55.FouriéT.G.GrardG.Leparc-GoffartI.BriolantS.FontaineA.Variability of"/>
  <result pre="Zika virus from a vasectomised manLancet Infect. Dis.201616110710.1016/S1473-3099(16)30320-6 55.FouriéT.G.GrardG.Leparc-GoffartI.BriolantS.FontaineA.Variability of" exact="Zika" post="Virus Incubation Period in HumansOpen Forum Infect. Dis.20185ofy26110.1093/ofid/ofy26130397624 56.Krow-LucalE.R.BiggerstaffB.J.StaplesJ.Estimated"/>
  <result pre="Period in HumansOpen Forum Infect. Dis.20185ofy26110.1093/ofid/ofy26130397624 56.Krow-LucalE.R.BiggerstaffB.J.StaplesJ.Estimated Incubation Period for" exact="Zika" post="Virus DiseaseEmerg. Infect. Dis.20172384184510.3201/eid2305.16171528277198 57.MansuyJ.M.SuberbielleE.Chapuy-RegaudS.MengelleC.BujanL.MarchouB.DelobelP.Gonzalez-DuniaD.MalnouC.E.IzopetJ.Zika virus in semen and"/>
  <result pre="semen and spermatozoaLancet Infect. Dis.2016161106110710.1016/S1473-3099(16)30336-X27676340 58.YockeyL.J.VarelaL.RakibT.Khoury-HanoldW.FinkS.L.StutzB.Szigeti-BuckK.Van den PolA.LindenbachB.D.HorvathT.L.J.C.Vaginal exposure to" exact="Zika" post="virus during pregnancy leads to fetal brain infectionCell20161661247125610.1016/j.cell.2016.08.00427565347 59.MinerJ.J.SeneA.RichnerJ.M.SmithA.M.SantefordA.BanN.Weger-LucarelliJ.ManzellaF.RückertC.GoveroJ.J.C.Zika"/>
  <result pre="virus in the male reproductive tractViruses20181019810.3390/v1004019829659541 62.LazearH.M.GoveroJ.SmithA.M.PlattD.J.FernandezE.MinerJ.J.DiamondM.S.J.A mouse model of" exact="Zika" post="virus pathogenesisCell Host Microbe20161972073010.1016/j.chom.2016.03.01027066744 63.WangA.ThurmondS.IslasL.HuiK.HaiR.Zika virus genome biology and"/>
  <result pre="damage in central nervous system of fatal cases microcephaly by" exact="Zika" post="virusSci. Rep.20188110.1038/s41598-017-17765-529311619 73.WangW.LiG.DeW.LuoZ.PanP.TianM.WangY.XiaoF.LiA.WuK.et al.Zika virus infection induces host inflammatory"/>
  <result pre="and Fetal DevelopmentImmunity20184939741210.1016/j.immuni.2018.07.01730231982 77.YockeyL.J.JuradoK.A.AroraN.MilletA.RakibT.MilanoK.M.HastingsA.K.FikrigE.KongY.HorvathT.L.J.Type I interferons instigate fetal demise after" exact="Zika" post="virus infectionSci. Immunol.20183eaao168010.1126/sciimmunol.aao168029305462 78.SadlerA.J.WilliamsB.R.J.N.Interferon-inducible antiviral effectorsNat. Rev. Immunol.2008855910.1038/nri231418575461 79.ZhangH.HeZ.ZengW.PengH.-J.Roles"/>
  <result pre="effectorsNat. Rev. Immunol.2008855910.1038/nri231418575461 79.ZhangH.HeZ.ZengW.PengH.-J.Roles of Interferons in Pregnant Women with" exact="Dengue" post="Infection: Protective or Dangerous FactorsCan. J. Infect. Dis. Med."/>
  <result pre="in epithelial cellsVirol. J.20151215010.1186/s12985-015-0383-426411318 85.ChaudharyV.YuenK.-S.ChanJ.F.-W.ChanC.-P.WangP.-H.CaiJ.-P.ZhangS.LiangM.KokK.-H.ChanC.-P.Selective activation of interferon-γ signaling by" exact="Zika" post="virus NS5 proteinJ. Virol.201791e00163-1710.1128/JVI.00163-1728468880 86.BowenJ.R.QuickeK.M.MaddurM.S.O’NealJ.T.McDonaldC.E.FedorovaN.B.PuriV.ShabmanR.S.PulendranB.SutharM.S.Zika virus antagonizes type I"/>
  <result pre="tissue responses in the maternal-fetal interfaceJ. Virol.201791e01905-1610.1128/JVI.01905-1627974560 88.SavidisG.PerreiraJ.M.PortmannJ.M.MeranerP.GuoZ.GreenS.BrassA.L.J.C.The IFITMs inhibit" exact="Zika" post="virus replicationCell Rep.2016152323233010.1016/j.celrep.2016.05.07427268505 89.ChesarinoN.M.McMichaelT.M.YountJ.S.E3 ubiquitin ligase NEDD4 promotes influenza"/>
  <result pre="signalingEMBO Rep.2016171766177510.15252/embr.20164262727797853 98.SironiM.ForniD.ClericiM.CaglianiR.J.P.Nonstructural proteins are preferential positive selection targets in" exact="Zika" post="virus and related flavivirusesPLoS Negl. Trop. Dis.201610e000497810.1371/journal.pntd.000497827588756 99.MaJ.KetkarH.GengT.LoE.WangL.XiJ.SunQ.ZhuZ.CuiY.YangL.J.F.Zika Virus"/>
  <result pre="by the New York 99 strain and Kunjin subtype of" exact="West Nile" post="virus involves blockage of STAT1 and STAT2 activation by"/>
  <result pre="nonstructural proteinsJ. Virol.2005791934194210.1128/JVI.79.3.1934-1942.200515650219 102.LiuW.J.WangX.J.ClarkD.C.LobigsM.HallR.A.KhromykhA.A.A single amino acid substitution in the" exact="West Nile" post="virus nonstructural protein NS2A disables its ability to inhibit"/>
  <result pre="inhibit neurogenesis and induce autophagyCell Stem Cell20161966367110.1016/j.stem.2016.07.01927524440 106.DurbinA.P.Vaccine Development for" exact="Zika" post="Virus—Timelines and StrategiesSeminars in Reproductive MedicineThieme Medical PublishersStuttgart, Germany2016299304"/>
  <result pre="in Reproductive MedicineThieme Medical PublishersStuttgart, Germany2016299304 107.RichnerJ.M.JaggerB.W.ShanC.FontesC.R.DowdK.A.CaoB.HimansuS.CaineE.A.NunesB.T.MedeirosD.B.J.C.Vaccine mediated protection against" exact="Zika" post="virus-induced congenital diseaseCell201717027328310.1016/j.cell.2017.06.04028708997 108.MunjalA.KhandiaR.DhamaK.SachanS.KarthikK.TiwariR.MalikY.S.KumarD.SinghR.K.IqbalH.Advances in developing therapies to combat"/>
  <result pre="Zika virus-induced congenital diseaseCell201717027328310.1016/j.cell.2017.06.04028708997 108.MunjalA.KhandiaR.DhamaK.SachanS.KarthikK.TiwariR.MalikY.S.KumarD.SinghR.K.IqbalH.Advances in developing therapies to combat" exact="Zika" post="virus: Current knowledge and future perspectivesFront. Microbiol.20178146910.3389/fmicb.2017.0146928824594 109.SacramentoC.Q.De MeloG.R.De"/>
  <result pre="Microbiol.20178146910.3389/fmicb.2017.0146928824594 109.SacramentoC.Q.De MeloG.R.De FreitasC.S.RochaN.HoelzL.V.B.MirandaM.Fintelman-RodriguesN.MarttorelliA.FerreiraA.C.Barbosa-LimaG.J.S.The clinically approved antiviral drug sofosbuvir inhibits" exact="Zika" post="virus replicationSci. Rep.201774092010.1038/srep4092028098253 110.DelvecchioR.HigaL.M.PezzutoP.ValadãoA.L.GarcezP.P.MonteiroF.L.LoiolaE.C.DiasA.A.SilvaF.J.AliotaM.T.Chloroquine, an endocytosis blocking agent, inhibits"/>
  <result pre="Zika virus replicationSci. Rep.201774092010.1038/srep4092028098253 110.DelvecchioR.HigaL.M.PezzutoP.ValadãoA.L.GarcezP.P.MonteiroF.L.LoiolaE.C.DiasA.A.SilvaF.J.AliotaM.T.Chloroquine, an endocytosis blocking agent, inhibits" exact="Zika" post="virus infection in different cell modelsViruses2016832210.3390/v812032227916837 111.BalasubramanianA.TeramotoT.KulkarniA.A.BhattacharjeeA.K.PadmanabhanR.Antiviral activities of"/>
  <result pre="activities of selected antimalarials against dengue virus type 2 and" exact="Zika" post="virusAntivir. Res.201713714115010.1016/j.antiviral.2016.11.01527889529 112.AkpovwaH.Chloroquine could be used for the treatment"/>
  <result pre="the Natural Polyphenols Delphinidin and Epigallocatechin Gallate against the Flaviviruses" exact="West Nile" post="Virus, Zika Virus, and Dengue VirusFront. Microbiol.20178131410.3389/fmicb.2017.0131428744282 114.GaudryA.BosS.ViranaickenW.RocheM.Krejbich-TrototP.GadeaG.DesprèsP.El-KalamouniC.The Flavonoid"/>
  <result pre="Delphinidin and Epigallocatechin Gallate against the Flaviviruses West Nile Virus," exact="Zika" post="Virus, and Dengue VirusFront. Microbiol.20178131410.3389/fmicb.2017.0131428744282 114.GaudryA.BosS.ViranaickenW.RocheM.Krejbich-TrototP.GadeaG.DesprèsP.El-KalamouniC.The Flavonoid Isoquercitrin Precludes"/>
  <result pre="Gallate against the Flaviviruses West Nile Virus, Zika Virus, and" exact="Dengue" post="VirusFront. Microbiol.20178131410.3389/fmicb.2017.0131428744282 114.GaudryA.BosS.ViranaickenW.RocheM.Krejbich-TrototP.GadeaG.DesprèsP.El-KalamouniC.The Flavonoid Isoquercitrin Precludes Initiation of Zika"/>
  <result pre="and Dengue VirusFront. Microbiol.20178131410.3389/fmicb.2017.0131428744282 114.GaudryA.BosS.ViranaickenW.RocheM.Krejbich-TrototP.GadeaG.DesprèsP.El-KalamouniC.The Flavonoid Isoquercitrin Precludes Initiation of" exact="Zika" post="Virus Infection in Human CellsInt. J. Mol. Sci.201819109310.3390/ijms1904109329621184 115.RauschK.HackettB.A.WeinbrenN.L.ReederS.M.SadovskyY.HunterC.A.SchultzD.C.CoyneC.B.CherryS.Screening"/>
  <result pre="Bioactives Reveals Nanchangmycin as a Broad Spectrum Antiviral Active against" exact="Zika" post="VirusCell Rep.20171880481510.1016/j.celrep.2016.12.06828099856 116.BatistaM.N.BragaA.C.S.CamposG.R.F.SouzaM.M.MatosR.P.A.D.LopesT.Z.BittarC.Natural Products Isolated from Oriental Medicinal Herbs"/>
  <result pre="VirusCell Rep.20171880481510.1016/j.celrep.2016.12.06828099856 116.BatistaM.N.BragaA.C.S.CamposG.R.F.SouzaM.M.MatosR.P.A.D.LopesT.Z.BittarC.Natural Products Isolated from Oriental Medicinal Herbs Inactivate" exact="Zika" post="VirusViruses2019114910.3390/v1101004930641880 117.HuchM.KooB.-K.Modeling mouse and human development using organoid culturesDevelopment20151423113312510.1242/dev.11857026395140"/>
  <result pre="human placentaJ. Matern.-Fetal Neonatal Med.2016291046105410.3109/14767058.2015.103851826075842 Figure 1 The structure of" exact="Zika" post="virus (ZIKV) genome and its encoded proteins. The single"/>
  <result pre="NS5). Figure 2 Innate immune evasion mechanisms by ZIKV. During" exact="ZIKV" post="infection, viral RNA sensors and interferon-mediated signaling through downstream"/>
 </snippets>
</snippetsTree>
